2026-07-23Bullish
+7.46%24 hours changeDanaher surged 7.46% as strong peer earnings from Thermo Fisher validated a life sciences recovery after an overdone sell-off.
read the report →Danaher Corporation is a globally diversified conglomerate specializing in the design, manufacturing, and marketing of professional, medical, industrial, and commercial products and services. Its core operations span three primary segments: Biotechnology, Life Sciences, and Diagnostics.
stitched from the price window carried by each report
Danaher surged 7.46% as strong peer earnings from Thermo Fisher validated a life sciences recovery after an overdone sell-off.
read the report →Danaher deferred over $100M in bioprocessing revenue into 2027 and cut segment guidance despite beating Q2 estimates.
read the report →